Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

This study has been terminated.
(stopped after planned interim analysis for lack of efficacy)
Information provided by:
Gustave Roussy, Cancer Campus, Grand Paris Identifier:
First received: June 29, 2006
Last updated: February 5, 2013
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)